What is the management and treatment for fifth disease (erythema infectiosum)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management and Treatment of Fifth Disease (Erythema Infectiosum)

Primary Management Approach

Fifth disease is a self-limiting viral illness that requires only supportive care in immunocompetent individuals, with treatment focused on symptom relief rather than antiviral therapy. 1

Treatment by Patient Population

Healthy Children and Adults

  • No specific antiviral treatment is indicated 1
  • Provide symptomatic relief with antipyretics for fever and analgesics for discomfort 1
  • NSAIDs or acetaminophen can be used for associated arthralgia, which occurs in approximately 50% of adults 1
  • Pruritus, present in approximately 50% of cases, can be managed with antihistamines 1
  • The rash typically resolves spontaneously within 3 weeks without sequelae 1

Pregnant Women

  • Assess maternal immune status immediately with parvovirus B19 IgG serology 2
  • If IgG positive (immune): No further intervention needed; fetal risk is nil 2
  • If IgG negative (non-immune): Initiate serial fetal surveillance despite low risk 2
    • Perform repeated ultrasonographic examinations to detect hydrops fetalis 2, 3
    • Reevaluate maternal immune status (IgM and IgG) 2
    • If fetal hydrops develops, refer immediately to tertiary care center for intrauterine evaluation and potential intrauterine transfusion 2
  • Continue ultrasound monitoring throughout pregnancy even if initial scans are normal 3

Immunocompromised Patients

  • Monitor for chronic anemia and persistent infection 4
  • Consider intravenous immunoglobulin (IVIG) for persistent parvovirus B19 infection causing chronic anemia 4
  • Serial complete blood counts to detect aplastic crisis 4

Patients with Hemolytic Anemia

  • Monitor closely for transient aplastic crisis 4
  • Obtain immediate complete blood count if patient develops sudden pallor, fatigue, or decreased hemoglobin 4
  • Hospitalize for supportive care including potential blood transfusion if aplastic crisis occurs 4

Critical Complications Requiring Intervention

Refractory Status Epilepticus from Encephalitis

  • Administer high-dose corticosteroids if parvovirus B19 encephalitis is confirmed 5
  • This rare complication requires intensive care management 5

Arthropathy in Adults

  • Joint symptoms are more common in adults than children, with the rash being less pronounced 1
  • Only 20% of affected adults develop facial erythema 1
  • NSAIDs provide adequate symptom control in most cases 1
  • Arthralgia typically resolves without long-term sequelae 4

Diagnostic Confirmation When Needed

  • Clinical diagnosis is sufficient in typical presentations with "slapped cheek" appearance and lacy reticular rash on extremities 1
  • Serologic testing (IgM and IgG) is available and reliable for atypical cases or high-risk patients 4, 2
  • Laboratory confirmation is essential for pregnant women, immunocompromised patients, and those with hemolytic disorders 2

Key Clinical Pitfalls to Avoid

  • Do not prescribe antibiotics; this is a viral illness 1
  • Do not overlook pregnancy status in women of childbearing age with exposure 2
  • Do not dismiss joint complaints in adults as unrelated; arthropathy occurs in the majority of adult cases 1
  • Do not assume immunity without serologic confirmation in high-risk exposures 2

References

Research

Erythema Infectiosum: A Narrative Review.

Current pediatric reviews, 2024

Research

Erythema infectiosum (Fifth disease) and pregnancy.

Canadian family physician Medecin de famille canadien, 1999

Research

Fifth (human parvovirus) and sixth (herpesvirus 6) diseases.

Current opinion in infectious diseases, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.